Drugs for chemotherapy and prophylaxis of influenza: Mechanisms, efficacy, and safety (a review)
作者： I. A. Leneva , R. G. Glushkov , T. A. Gus’kova
DOI: 10.1007/S11094-005-0036-9
关键词: Chemistry 、 Pharmacy 、 Chemotherapy 、 Pharmacology toxicology 、 Pharmacology 、 Intensive care medicine
摘要: Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 38, No. 11, pp. 8 – 14, November, 2004.
springer.com
sci-hub.se 参考文章(34)
Kevin R. Murphy, Arne Eivindson, Karlis Pauksens, William J. Stein, Guy Tellier, Richard Watts, Paul L??ophonte, Stephen J. Sharp, Elke Loeschel, Efficacy and Safety of Inhaled Zanamivir for the Treatment of Influenza in Patients with Asthma or Chronic Obstructive Pulmonary Disease Clinical Drug Investigation. ,vol. 20, pp. 337- 349 ,(2000) , 10.2165/00044011-200020050-00005
J.S. Oxford, Chemoprophylaxis and Virus Infections of the Respiratory Tract CRC Press. ,(2018) , 10.1201/9781351070614
Yahachi Saito, Koji Hamaguchi, Koichi Hata, Kunio Uchida, Yoshiharu Tasaka, Fumikazu Ikazaki, Motoo Yumura, Atsuo Kasuya, Yuichiro Nishina, Conical beams from open nanotubes Nature. ,vol. 389, pp. 554- 555 ,(1997) , 10.1038/39221
Robert B. Belshe, Betty Burk, Frances Newman, Richard L. Cerruti, Iain S. Sim, Resistance of Influenza A Virus to Amantadine and Rimantadine: Results of One Decade of Surveillance The Journal of Infectious Diseases. ,vol. 159, pp. 430- 435 ,(1989) , 10.1093/INFDIS/159.3.430
VICTOR W HORADAM, James G Sharp, Jerry D Smilack, BILL H McANALLEY, James C Garriott, Michael K Stephens, Ronald C Prati, D Craig Brater, Pharmacokinetics of Amantadine Hydrochloride in Subjects with Normal and Impaired Renal Function Annals of Internal Medicine. ,vol. 94, pp. 454- 458 ,(1981) , 10.7326/0003-4819-94-4-454
Arnold S. Monto, D. Paul Robinson, M. Louise Herlocher, James M. Hinson, Jr, Michael J. Elliott, Adam Crisp, Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. JAMA. ,vol. 282, pp. 31- 35 ,(1999) , 10.1001/JAMA.282.1.31
Dirk B. Mendel, Robert W. Sidwell, Influenza virus resistance to neuraminidase inhibitors Drug Resistance Updates. ,vol. 1, pp. 184- 189 ,(1998) , 10.1016/S1368-7646(98)80038-1
John J. Treanor, Frederick G. Hayden, Peter S. Vrooman, Rick Barbarash, Robert Bettis, Dennis Riff, Sudeep Singh, Nelson Kinnersley, Penelope Ward, Roger G. Mills, for the US Oral Neuraminidase Study Group, Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza JAMA. ,vol. 283, pp. 1016- 1024 ,(2000) , 10.1001/JAMA.283.8.1016
R L Tominack, R J Wills, L E Gustavson, F G Hayden, Multiple-dose pharmacokinetics of rimantadine in Elderly adults Antimicrobial Agents and Chemotherapy. ,vol. 32, pp. 1813- 1819 ,(1988) , 10.1128/AAC.32.12.1813
W. L. Wingfield, David Pollack, R. R. Grunert, Therapeutic Efficacy of Amantadine HCl and Rimantadine HCl in Naturally Occurring Influenza A2 Respiratory Illness in Man New England Journal of Medicine. ,vol. 281, pp. 579- 584 ,(1969) , 10.1056/NEJM196909112811102